 1. Subjects participating in this study must have completed treatment and all required evaluations in the previous MBP8298-01 study A Double Blind Placebo Controlled Multi-Centre Study to Evaluate the Efficacy and Safety of MBP8298 in Subjects with Secondary Progressive Multiple Sclerosis, 